Spots Global Cancer Trial Database for tamoxifen citrate
Every month we try and update this database with for tamoxifen citrate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole | NCT00077168 | Breast Cancer | anastrozole tamoxifen citra... adjuvant therap... radiation thera... | 40 Years - 70 Years | National Cancer Institute (NCI) | |
| Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer | NCT00003016 | Breast Cancer | tamoxifen citra... adjuvant therap... | - | National Cancer Institute (NCI) | |
| Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes | NCT00007904 | Breast Cancer | filgrastim cyclophosphamid... doxorubicin hyd... paclitaxel tamoxifen citra... adjuvant therap... radiation thera... | 18 Years - | Case Comprehensive Cancer Center | |
| Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I Breast Cancer | NCT00002720 | Breast Cancer | tamoxifen citra... conventional su... | 65 Years - 80 Years | National Cancer Institute (NCI) | |
| Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer | NCT00002646 | Breast Cancer | fenretinide tamoxifen citra... | - | National Cancer Institute (NCI) | |
| Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer | NCT00002680 | Breast Cancer | filgrastim cyclophosphamid... megestrol aceta... melphalan tamoxifen citra... thiotepa conventional su... peripheral bloo... radiation thera... | 18 Years - | Yale University | |
| Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes | NCT00004125 | Breast Cancer | cyclophosphamid... docetaxel doxorubicin hyd... paclitaxel tamoxifen citra... radiation thera... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole | NCT00077168 | Breast Cancer | anastrozole tamoxifen citra... adjuvant therap... radiation thera... | 40 Years - 70 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Women With Breast Cancer | NCT00003679 | Breast Cancer | cyclophosphamid... docetaxel doxorubicin hyd... tamoxifen citra... conventional su... radiation thera... | 18 Years - 60 Years | National Cancer Institute (NCI) | |
| S9630, Medroxyprogesterone in Treating Women With Breast Cancer | NCT00002920 | Breast Cancer Endometrial Can... | medroxyprogeste... tamoxifen citra... adjuvant therap... | 18 Years - | SWOG Cancer Research Network | |
| Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer | NCT00005908 | Breast Cancer Breast Neoplasm | Docetaxel - Dos... Anastrozole cyclophosphamid... Docetaxel - Dos... Doxorubicin hyd... Tamoxifen Citra... Capecitabine - ... Capecitabine - ... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer | NCT00601900 | Invasive Breast... Recurrent Breas... Stage III Breas... Stage IV Breast... | Bevacizumab Laboratory Biom... Letrozole Questionnaire A... Tamoxifen Citra... | 18 Years - | National Cancer Institute (NCI) | |
| Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer | NCT00003016 | Breast Cancer | tamoxifen citra... adjuvant therap... | - | National Cancer Institute (NCI) | |
| Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer | NCT00424164 | Breast Cancer | lapatinib ditos... tamoxifen citra... pharmacological... | 18 Years - 120 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | NCT00041080 | Fallopian Tube ... Primary Periton... Recurrent Ovari... Stage III Ovari... Stage IV Ovaria... | tamoxifen citra... thalidomide laboratory biom... | - | National Cancer Institute (NCI) | |
| Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer | NCT00003080 | Ovarian Cancer | endocrine-modul... melphalan mitoxantrone hy... tamoxifen citra... thiotepa peripheral bloo... | 18 Years - 60 Years | Fred Hutchinson Cancer Center | |
| Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery | NCT00398489 | Breast Cancer | trastuzumab anastrozole cyclophosphamid... docetaxel epirubicin hydr... goserelin aceta... tamoxifen citra... adjuvant therap... conventional su... neoadjuvant the... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Comparison of Four Different Treatment Regimens in Treating Women With Stage I Breast Cancer | NCT00006030 | Breast Cancer | tamoxifen citra... conventional su... radiation thera... | - 70 Years | National Cancer Institute (NCI) | |
| S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer | NCT01674140 | Breast Cancer | anastrozole everolimus exemestane goserelin aceta... letrozole leuprolide acet... tamoxifen citra... placebo | 18 Years - | SWOG Cancer Research Network | |
| Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer | NCT00003035 | Breast Cancer | filgrastim doxorubicin hyd... paclitaxel tamoxifen citra... surgical proced... radiation thera... | 18 Years - | Georgetown University | |
| Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer | NCT00002580 | Breast Cancer | cyclophosphamid... fluorouracil goserelin aceta... leuprolide acet... methotrexate tamoxifen citra... conventional su... laparoscopic su... oophorectomy radiation thera... | - 70 Years | National Cancer Institute (NCI) | |
| Phase II Study of Everolimus Beyond Progression | NCT02269670 | Estrogen Recept... HER2-negative B... Progesterone Re... Recurrent Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... | everolimus anastrozole letrozole tamoxifen citra... fulvestrant megestrol aceta... | 19 Years - | Emory University | |
| Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes | NCT00007904 | Breast Cancer | filgrastim cyclophosphamid... doxorubicin hyd... paclitaxel tamoxifen citra... adjuvant therap... radiation thera... | 18 Years - | Case Comprehensive Cancer Center | |
| Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors | NCT00541138 | Brain and Centr... Metastatic Canc... Unspecified Adu... | carboplatin tamoxifen citra... topotecan hydro... pharmacological... | 18 Years - | City of Hope Medical Center | |
| Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer | NCT00002646 | Breast Cancer | fenretinide tamoxifen citra... | - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors | NCT00002608 | Adrenocortical ... Brain and Centr... Head and Neck C... Liver Cancer Malignant Mesot... Pheochromocytom... Sarcoma | cisplatin doxorubicin hyd... tamoxifen citra... conventional su... radiation thera... | - 65 Years | National Cancer Institute (NCI) | |
| Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer | NCT00003050 | Breast Cancer | cyclophosphamid... doxorubicin hyd... paclitaxel tamoxifen citra... surgical proced... radiation thera... | 18 Years - | University of Southern California | |
| Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer | NCT00003680 | Breast Cancer | CMF regimen cyclophosphamid... fluorouracil methotrexate tamoxifen citra... thiotepa peripheral bloo... radiation thera... | 18 Years - 60 Years | National Cancer Institute (NCI) | |
| Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy | NCT00053898 | Breast Cancer | anastrozole tamoxifen citra... Radiation Thera... | - | NSABP Foundation Inc | |
| Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer | NCT00016276 | Cardiac Toxicit... Inflammatory Br... Stage IIIA Brea... Stage IIIB Brea... Stage IV Breast... | dexrazoxane hyd... doxorubicin hyd... cyclophosphamid... paclitaxel trastuzumab therapeutic con... radiation thera... tamoxifen citra... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | NCT00041080 | Fallopian Tube ... Primary Periton... Recurrent Ovari... Stage III Ovari... Stage IV Ovaria... | tamoxifen citra... thalidomide laboratory biom... | - | National Cancer Institute (NCI) | |
| CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen | NCT00305838 | Fallopian Tube ... Ovarian Cancer Primary Periton... | tamoxifen citra... diagnostic labo... | - | National Cancer Institute (NCI) | |
| S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer | NCT01674140 | Breast Cancer | anastrozole everolimus exemestane goserelin aceta... letrozole leuprolide acet... tamoxifen citra... placebo | 18 Years - | SWOG Cancer Research Network | |
| Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ | NCT00072462 | Breast Cancer | tamoxifen citra... Anastrozole | 40 Years - 70 Years | Queen Mary University of London | |
| S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer | NCT00002772 | Breast Cancer | filgrastim carboplatin carmustine cisplatin cyclophosphamid... doxorubicin hyd... paclitaxel tamoxifen citra... thiotepa autologous bone... peripheral bloo... radiation thera... | 18 Years - | SWOG Cancer Research Network | |
| Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen | NCT00764322 | Breast Cancer Menopausal Symp... | tamoxifen citra... gene expression... pharmacogenomic... questionnaire a... quality-of-life... | 21 Years - 120 Years | UNC Lineberger Comprehensive Cancer Center | |
| Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer | NCT00002580 | Breast Cancer | cyclophosphamid... fluorouracil goserelin aceta... leuprolide acet... methotrexate tamoxifen citra... conventional su... laparoscopic su... oophorectomy radiation thera... | - 70 Years | National Cancer Institute (NCI) | |
| Tipifarnib Plus Tamoxifen in Treating Women With Metastatic Breast Cancer | NCT00052728 | Breast Cancer | tamoxifen citra... tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer | NCT00002680 | Breast Cancer | filgrastim cyclophosphamid... megestrol aceta... melphalan tamoxifen citra... thiotepa conventional su... peripheral bloo... radiation thera... | 18 Years - | Yale University | |
| Combination Chemotherapy in Treating Women With Breast Cancer | NCT00047099 | Breast Cancer | cyclophosphamid... docetaxel epirubicin hydr... fluorouracil goserelin aceta... tamoxifen citra... adjuvant therap... radiation thera... | 18 Years - 70 Years | National Cancer Institute (NCI) | |
| Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ | NCT00003857 | Breast Cancer | tamoxifen citra... adjuvant therap... radiation thera... | 26 Years - 120 Years | Radiation Therapy Oncology Group | |
| Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer | NCT00016341 | Endometrial Can... | filgrastim cisplatin doxorubicin hyd... megestrol aceta... paclitaxel tamoxifen citra... | - | GOG Foundation | |
| Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer | NCT00053911 | Breast Cancer | anastrozole cyclophosphamid... docetaxel epirubicin hydr... fluorouracil goserelin aceta... tamoxifen citra... adjuvant therap... | 18 Years - 65 Years | UNICANCER | |
| Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer | NCT00002582 | Breast Cancer | CMF regimen cyclophosphamid... doxorubicin hyd... fluorouracil goserelin aceta... leuprolide acet... methotrexate tamoxifen citra... oophorectomy radiation thera... | - | National Cancer Institute (NCI) | |
| Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast Cancer | NCT00893061 | Breast Cancer | anastrozole exemestane letrozole tamoxifen citra... | - 70 Years | National Cancer Institute (NCI) | |
| Radiation Therapy and Tamoxifen in Treating Children With Newly Diagnosed Brain Stem Glioma | NCT00024336 | Brain and Centr... | tamoxifen citra... radiation thera... | - 19 Years | National Cancer Institute (NCI) | |
| Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer | NCT00002528 | Breast Cancer | tamoxifen citra... conventional su... radiation thera... Axillary cleara... | 60 Years - | ETOP IBCSG Partners Foundation | |
| High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer | NCT00003032 | Breast Cancer | filgrastim cisplatin cyclophosphamid... mitoxantrone hy... tamoxifen citra... | 16 Years - 60 Years | Canadian Cancer Trials Group | |
| Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer | NCT00002967 | Breast Cancer | cyclophosphamid... doxorubicin hyd... octreotide pamo... tamoxifen citra... | - | National Cancer Institute (NCI) | |
| Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme | NCT00006388 | Brain and Centr... | tamoxifen citra... radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
| Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors | NCT01196936 | Breast Cancer | Tamoxifen Citra... Placebo Digital mammogr... immunohistochem... pharmacological... laboratory biom... protein express... pharmacogenomic... questionnaire a... Fine needle asp... Quality of Life... | 25 Years - | University of Alabama at Birmingham | |
| Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer | NCT00005970 | Breast Adenocar... HER2 Positive B... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... | Aromatase Inhib... Cyclophosphamid... Doxorubicin Hyd... Laboratory Biom... Paclitaxel Tamoxifen Citra... Trastuzumab | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer | NCT00003080 | Ovarian Cancer | endocrine-modul... melphalan mitoxantrone hy... tamoxifen citra... thiotepa peripheral bloo... | 18 Years - 60 Years | Fred Hutchinson Cancer Center | |
| Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer | NCT00016341 | Endometrial Can... | filgrastim cisplatin doxorubicin hyd... megestrol aceta... paclitaxel tamoxifen citra... | - | GOG Foundation | |
| Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer | NCT00873366 | Breast Cancer | dextromethorpha... tamoxifen citra... high performanc... laboratory biom... pharmacogenomic... pharmacological... fluorescence im... | 18 Years - 120 Years | Mayo Clinic | |
| Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer | NCT00009997 | Breast Cancer | trastuzumab cyclophosphamid... doxorubicin hyd... paclitaxel tamoxifen citra... conventional su... | 18 Years - | NYU Langone Health | |
| Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen | NCT00764322 | Breast Cancer Menopausal Symp... | tamoxifen citra... gene expression... pharmacogenomic... questionnaire a... quality-of-life... | 21 Years - 120 Years | UNC Lineberger Comprehensive Cancer Center | |
| Phase II Study of Everolimus Beyond Progression | NCT02269670 | Estrogen Recept... HER2-negative B... Progesterone Re... Recurrent Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... | everolimus anastrozole letrozole tamoxifen citra... fulvestrant megestrol aceta... | 19 Years - | Emory University | |
| Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer | NCT00629278 | Breast Cancer | trastuzumab aromatase inhib... cyclophosphamid... docetaxel doxorubicin hyd... epirubicin hydr... fluorouracil paclitaxel releasing hormo... tamoxifen citra... adjuvant therap... radiation thera... | 18 Years - 75 Years | National Cancer Institute (NCI) | |
| Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen | NCT00118157 | Estrogen Recept... Male Breast Car... Progesterone Re... Recurrent Breas... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... | Laboratory Biom... Lapatinib Ditos... Tamoxifen Citra... | 18 Years - | National Cancer Institute (NCI) | |
| Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast | NCT02993159 | Ductal Breast C... Estrogen Recept... | Afimoxifene Laboratory Biom... Placebo Placebo Tamoxifen Citra... | 18 Years - | Northwestern University | |
| Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery | NCT00398489 | Breast Cancer | trastuzumab anastrozole cyclophosphamid... docetaxel epirubicin hydr... goserelin aceta... tamoxifen citra... adjuvant therap... conventional su... neoadjuvant the... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer | NCT00002967 | Breast Cancer | cyclophosphamid... doxorubicin hyd... octreotide pamo... tamoxifen citra... | - | National Cancer Institute (NCI) | |
| Tamoxifen in Treating Women With High-Risk Breast Cancer | NCT00002542 | Breast Cancer | CMF regimen cyclophosphamid... doxorubicin hyd... epirubicin hydr... fluorouracil methotrexate tamoxifen citra... radiation thera... | - 120 Years | Canadian Cancer Trials Group | |
| Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women) | NCT00499083 | Breast Cancer | therapeutic aut... aromatase inhib... cyclophosphamid... doxorubicin hyd... paclitaxel tamoxifen citra... gene expression... protein express... reverse transcr... immunoenzyme te... immunohistochem... laboratory biom... adjuvant therap... biopsy conventional su... neoadjuvant the... radiation thera... | 19 Years - 120 Years | University of Nebraska | |
| Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer | NCT00003050 | Breast Cancer | cyclophosphamid... doxorubicin hyd... paclitaxel tamoxifen citra... surgical proced... radiation thera... | 18 Years - | University of Southern California | |
| Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2 | NCT00003992 | Breast Cancer | trastuzumab cyclophosphamid... doxorubicin hyd... paclitaxel tamoxifen citra... | 18 Years - | National Cancer Institute (NCI) | |
| Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen | NCT00764322 | Breast Cancer Menopausal Symp... | tamoxifen citra... gene expression... pharmacogenomic... questionnaire a... quality-of-life... | 21 Years - 120 Years | UNC Lineberger Comprehensive Cancer Center | |
| Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors | NCT02197897 | Bladder Cancer | Tamoxifen Citra... | 21 Years - | Baylor College of Medicine | |
| Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer | NCT03917082 | Breast Cancer F... Hormone Recepto... | Tamoxifen Citra... | 51 Years - | British Columbia Cancer Agency | |
| Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) | NCT00310180 | Breast Adenocar... Hormone Recepto... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIB Brea... | Anastrozole Exemestane Laboratory Biom... Letrozole Quality-of-Life... Radiation Thera... Tamoxifen Citra... | 18 Years - 75 Years | National Cancer Institute (NCI) | |
| Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer | NCT00002529 | Breast Cancer | cyclophosphamid... doxorubicin hyd... epirubicin hydr... tamoxifen citra... toremifene | - 70 Years | ETOP IBCSG Partners Foundation | |
| Tamoxifen Resistance in Women With Stage I, Stage II, Stage IIIA, or Stage IIIB Breast Cancer | NCT00899197 | Breast Cancer | tamoxifen citra... gene expression... protein express... immunoenzyme te... laboratory biom... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast Cancer | NCT00893061 | Breast Cancer | anastrozole exemestane letrozole tamoxifen citra... | - 70 Years | National Cancer Institute (NCI) | |
| Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer | NCT00002777 | Breast Cancer | exemestane tamoxifen citra... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors | NCT00541138 | Brain and Centr... Metastatic Canc... Unspecified Adu... | carboplatin tamoxifen citra... topotecan hydro... pharmacological... | 18 Years - | City of Hope Medical Center | |
| CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen | NCT00305838 | Fallopian Tube ... Ovarian Cancer Primary Periton... | tamoxifen citra... diagnostic labo... | - | National Cancer Institute (NCI) | |
| Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer | NCT00002460 | Breast Cancer | goserelin aceta... tamoxifen citra... ablative endocr... oophorectomy | - 49 Years | National Cancer Institute (NCI) | |
| CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen | NCT00305838 | Fallopian Tube ... Ovarian Cancer Primary Periton... | tamoxifen citra... diagnostic labo... | - | National Cancer Institute (NCI) | |
| Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ | NCT00072462 | Breast Cancer | tamoxifen citra... Anastrozole | 40 Years - 70 Years | Queen Mary University of London |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
